Newsletters

  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
All
  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
R&D InsightY2017

Workshop on TB drugs: Lessons for the antibacterial community

Dear All: ​I listened with interest to the 19 July 2017 FDA Workshop entitled “Development of New Tuberculosis Treatment Regimens– …

Read More >
IncentivesY2017

G20 declaration – Statements about action on AMR

Dear All: ​The G20 have released a declaration in which they specifically discuss their intent around AMR. See below a …

Read More >
IncentivesY2017

Lancet ID Commentary to the G20 on behalf of the DRIVE-AB Steering Committee

I am pleased to say that a commentary to the G20 on behalf of the DRIVE-AB Steering Committee has now …

Read More >
R&D InsightWonkish

Developing systemic & inhaled antibiotics for lung infections

Dear All: I missed it personally, but by all reports the session on 3 June 2017 at ASM Microbe entitled …

Read More >
IncentivesY2017

New European Action Plan on AMR

Dear All: ​An updated European One Health Action Plan on AMR was released today. See links and text excerpts below …

Read More >
R&D InsightY2017

Delafloxacin approval / Good example of a modern label

Dear All: FDA’s approval of delafloxacin (BAXDELA) was announced on 20 June 2017 and the label can be found here. In …

Read More >
R&D InsightY2017

FNIH’s submission to the HABP/VABP docket

Dear All: After a multi-year gestation period (my notes on this project go back to 2012!!), a comment on the …

Read More >
PK & PK-PDWonkish

NIAID workshop: What is a robust PK-PD package?

Dear All: The ~150 of us who gathered in Washington yesterday and today for the NIAID’s PK-PD workshop enjoyed a …

Read More >
IncentivesY2017

Assessing antibiotic value: Two papers on antibiotic-specific gaps in traditional Health Technology Assessments

Dear All: Among various paradoxes that surround antibiotic development, the challenge for health technology assessment (HTA) is often implied but …

Read More >
IncentivesY2017

Ardal et al. / Pull incentives for antibiotics – TATFAR analysis of 6 models

Dear All: ​The TATFAR group has a new and very helpful paper out in Clinical Infectious Diseases in which they analyze 6 …

Read More >
R&D InsightY2017

Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance

Dear All: Along with our co-authors (Mark Goldberger, Barry Eisenstein, Roger Echols, John Tomayko, Mike Dudley, and Aaron Dane), George Talbot …

Read More >
IncentivesY2017

G20 Health Minister’s declaration / Calls for push, pull, avoiding price/volume mechanisms, and support of global partnerships!

Dear All: Adding to the continued forward momentum of calls for support of antibiotic R&D, this week’s meeting of the G20 Health …

Read More >
IncentivesY2017

New OHE report on incentives for antibiotics

Dear All: Just hitting my inbox today is this report from OHE. The paper reviews in detail the incentive proposals in the 2016 O’Neill …

Read More >
R&D InsightWonkish

IDSA White Paper on developing narrow-spectrum antimicrobials + editorial by G. Drusano

Dear All (long note alert … there’s a lot of material below my signature): Just published today is an IDSA …

Read More >
PK & PK-PDWonkish

FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii

Dear All (and with apologies … long note alert!): Yesterday’s AMDAC was very productive. For reference, all the materials are here and …

Read More >
IncentivesR&D Insight

CARB-X funding round #1, SDRI 2017, & Antibiotic-tainted seafood

Dear All: Just in case you missed the 30 March annoucement, see at right a snapshot of the first 11 Powered …

Read More >
R&D InsightY2017

Antimicrobial Effects of Antipyretics, a paper in AAC by Zimmerman & Curtis

Dear All: OK, I’ll say that I’m sending this around because the title was so intriguing and reminded me of the …

Read More >
R&D InsightY2017

International Course on Antibiotics and Resistance ICARe, 11-19 Nov 2017

Dear All: FYI, see below an announcement of an 8-day intensive course in Paris in November 2017: “ICARe is designed …

Read More >
Media & GraphicsY2017

IDSA’s Faces of Antimicrobial Resistance (FAOR) report

Dear All: This one appears to have been released on 7 Mar but it just crossed my desk today. In …

Read More >
Media & GraphicsY2017

Useful AMR graphics: Poirel 2017 and Marston 2016

Dear All: There’s a very comprehensive review of the polymyxins by Poirel, Jayol, and Nordmann just out in Clin Micro …

Read More >
Scroll to Top